GoodRx Holdings (GoodRx Holdings) GF Value : $6.98 (As of May. 01, 2024)

View and export this data going back to 2020. Start your Free Trial

What is GoodRx Holdings GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-05-01), GoodRx Holdings's share price is $7.095. GoodRx Holdings's GF Value is $6.98. Therefore, GoodRx Holdings's Price-to-GF-Value for today is 1.02.

Based on the relationship between the current stock price and the GF Value, GuruFocus believes GoodRx Holdings is Fairly Valued.

GoodRx Holdings (NAS:GDRX) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

GoodRx Holdings's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	7.095	/	6.98
	=	1.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GoodRx Holdings GF Value Related Terms

Thank you for viewing the detailed overview of GoodRx Holdings's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

GoodRx Holdings (GoodRx Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » GoodRx Holdings Inc (NAS:GDRX) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

2701 Olympic Boulevard, Santa Monica, CA, USA, 90404

Website

https://www.goodrx.com

GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers other healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.

Executives

Scott Wagner	officer: Interim Chief Executive Office	C/O WILSON SONSINI GOODRICH AND ROSATI, 650 PAGE MILL ROAD, PALO ALTO CA 94304
Raj Beri	officer: Chief Operating Officer	C/O GOODRX HOLDINGS, INC., 2701 OLYMPIC BOULEVARD, SANTA MONICA CA 90404
Romin Nabiey	officer: Chief Accounting Officer	C/O GOODRX HOLDINGS, INC., 2701 OLYMPIC BOULEVARD, SANTA MONICA CA 90404
Andrew Slutsky	officer: President & Consumer	233 WILSHIRE ROAD, SANTA MONICA CA 90410
Idea Men, Llc	10 percent owner	2701 OLYMPIC BOULEVARD, WEST BUILDING - SUITE 200, SANTA MONICA CA 90404
Karsten Voermann	officer: Chief Financial Officer	233 WILSHIRE ROAD, SANTA MONICA CA 90410
Trevor Bezdek	director, officer: Co-CEO	233 WILSHIRE ROAD, SANTA MONICA CA 90410
Abdiel Qualified Master Fund Lp	10 percent owner	90 PARK AVENUE, 29TH FLOOR, NEW YORK NY 10016
Douglas Joseph Hirsch	director, officer: Co-CEO	233 WILSHIRE ROAD, SANTA MONICA CA 90410
Babak Azad	officer: See Remarks	233 WILSHIRE ROAD, SANTA MONICA CA 90410
Bansi Nagji	officer: President, Healthcare	MCKESSON CORPORATION, 6555 STATE HIGHWAY 161, IRVING TX 75039
Agnes Rey-giraud	director
Abdiel Capital Lp	10 percent owner	C/O ABDIEL CAPITAL ADVISORS, LP, 90 PARK AVENUE, 29TH FLOOR, NEW YORK NY 10016
Abdiel Capital Advisors, Lp	10 percent owner	90 PARK AVENUE, 29TH FLOOR, NEW YORK NY 10016
Abdiel Capital Management, Llc	10 percent owner	90 PARK AVENUE, 29TH FLOOR, NEW YORK NY 10016